PLA/PLGA-Based Drug Delivery Systems Produced with Supercritical CO2—A Green Future for Particle Formulation?

Gangapurwala, Gauri; Vollrath, Antje; Luis, Alicia De San; Schubert, Ulrich S.

doi:10.3390/pharmaceutics12111118

Cited by 35 publications

(27 citation statements)

References 122 publications

(113 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A similar result was demonstrated in our study (see Figure 3 b and Table A2 in Appendix A ). While these are the limitations of the current work, for the animal ethics considerations, we preferred to narrow the scope to the validation of the principal biological effects of PLA@PF implants first, before the further IDDS development (which is envisaged, in particular, via the adjustments of the scCO 2 compounds treatment conditions [ 73 ]).…”

Section: Discussionmentioning

confidence: 99%

Local Delivery of Pirfenidone by PLA Implants Modifies Foreign Body Reaction and Prevents Fibrosis

et al. 2021

View full text Add to dashboard Cite

Peri-implant fibrosis (PIF) increases the postsurgical risks after implantation and limits the efficacy of the implantable drug delivery systems (IDDS). Pirfenidone (PF) is an oral anti-fibrotic drug with a short (<3 h) circulation half-life and strong adverse side effects. In the current study, disk-shaped IDDS prototype combining polylactic acid (PLA) and PF, PLA@PF, with prolonged (~3 days) PF release (in vitro) was prepared. The effects of the PLA@PF implants on PIF were examined in the rabbit ear skin pocket model on postoperative days (POD) 30 and 60. Matching blank PLA implants (PLA0) and PLA0 with an equivalent single-dose PF injection performed on POD0 (PLA0+injPF) served as control. On POD30, the intergroup differences were observed in α-SMA, iNOS and arginase-1 expressions in PLA@PF and PLA0+injPF groups vs. PLA0. On POD60, PIF was significantly reduced in PLA@PF group. The peri-implant tissue thickness decreased (532 ± 98 µm vs. >1100 µm in control groups) approaching the intact derma thickness value (302 ± 15 µm). In PLA@PF group, the implant biodegradation developed faster, while arginase-1 expression was suppressed in comparison with other groups. This study proves the feasibility of the local control of fibrotic response on implants via modulation of foreign body reaction with slowly biodegradable PF-loaded IDDS.

show abstract

Section: Discussionmentioning

confidence: 99%

Local Delivery of Pirfenidone by PLA Implants Modifies Foreign Body Reaction and Prevents Fibrosis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The C6 cells were incubated and collected, and then cells at a density of 1×10 7 were suspended in 5 mL of lysis buffer containing 50 µL protease inhibitor cocktail. After being placed in an ice bath for 20 min, the C6 cells were repeatedly frozen and thawed ve times.…”

Section: Extraction Of Platelet Membrane and C6 Cell Membranementioning

confidence: 99%

“…Nanoparticle (NP)-based drug delivery systems have become a promising tool for improving the delivery and effectiveness of therapeutic drugs for tumors [5 6] . Poly (lactic-co-glycolic acid) (PLGA) is an excellent drug carrier owing to its biocompatibility, biodegradability, and toxicologically safe degradation products, and has been widely used in drug delivery [7] . Studies have extensively documented the functionalization of PLGA via various targeting ligands, such as peptides, antibodies, and nucleic acids [8] .…”

Section: Introductionmentioning

confidence: 99%

Platelet–Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma

Deng

et al. 2021

Preprint

View full text Add to dashboard Cite

Cell membrane-camouflaged nanoparticles are drawing increasing attention because their surfaces retain the natural functionalities of the cell plasma membranes, making them a unique class of biomimetic materials combining natural and synthetic components. Modifying the cell membranes or combining the functions of different types of membranes enhances their functionality. Herein, we prepared platelet and tumor cell membrane camouflaged antitumor nanoparticles. The effects of β-mangostin-loaded nanoparticles on the target and its anticancer action in glioma were measured in vitro and in vivo. Multifunctional nanoparticles were manufactured with platelet–C6 hybrid biomimetic coating (PCM), lactic-co-glycolic acid (PLGA), and β-mangostin. PCM increased the proportion of active drug targeting in C6 and immune escape characteristics in THP-1 cells, thus enhancing the cytotoxicity of β-PCNPs. The β-PCNPs were comprehensively characterized to study the inherent properties of both source cells. Compared with bare β-NPs, β-PCNPs exhibited high tumor-targeting ability and induced apoptosis of C6 cells in vitro. Mice experiments with intravenous administration of the drug revealed that the β-PCNP platform enhanced the tumor targeting capability and exhibited excellent chemotherapy with high inhibition rate of glioma tumor growth in vivo. The mice in the β-PCNP group had a markedly prolonged circulation lifetime and exhibited better outcome than those in the β-NP group. These results provide a new strategy of utilizing PCNPs as carriers for drug delivery, which improves the targeting efficiency and therapeutic efficacy of chemotherapeutic agents for glioma therapy.

show abstract

“… 7 Poly(lactic-co-glycolic acid) (PLGA) is an excellent drug carrier owing to its biocompatibility, biodegradability, and safe degradation products, and has been widely used in drug delivery. 8 Studies have extensively documented the functionalization of PLGA with various targeting ligands, such as peptides, antibodies, and nucleic acids. 9 However, nanomaterials are easily intercepted by macrophages, resulting in poor immunocompatibility.…”

Section: Introductionmentioning

confidence: 99%

Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma

Wu¹,

Li²,

Deng³

et al. 2021

IJN

View full text Add to dashboard Cite

Purpose Cell membrane-camouflaged nanoparticles (NPs) are drawing increasing attention because their surfaces acquire some characteristics of the cell membranes, making them a unique class of biomimetic materials for diverse applications. Modification of cell membrane or combination of different types of membranes can enhance their functionality. Methods We prepared platelet and tumor cell membrane camouflaged β-mangostin-loaded NPs, which were synthesized with platelet–C6 hybrid biomimetic coating, poly(lactic-co-glycolic acid), and β-mangostin (β-PCNPs). Then, we evaluated their targeting ability and anticancer activity against glioma in vitro and in vivo. Results Biomimetic coating enhanced active drug targeting and immune escape properties of nanocarrier in C6 and THP-1 cells, respectively, which improved their cytotoxicity. β-PCNPs were characterized to study the inherent properties of both source cells. Compared with bare β-NPs, β-PCNPs exhibited high tumor-targeting capability and induced apoptosis of C6 cells in vitro. Similarly, intravenous administration of drug through β-PCNPs resulted in enhanced tumor-targeting and exhibited excellent rate of inhibition of glioma tumor growth in mice. Moreover, the blood circulation time of drug in mice in the β-PCNP group was markedly prolonged and these mice exhibited better outcome than those in the β-NP group. Conclusion These results provide a new strategy of utilizing PCNPs as carriers for drug delivery, which improves the targeting efficiency and therapeutic efficacy of chemotherapeutic agents for glioma therapy.

show abstract

PLA/PLGA-Based Drug Delivery Systems Produced with Supercritical CO2—A Green Future for Particle Formulation?

Cited by 35 publications

References 122 publications

Local Delivery of Pirfenidone by PLA Implants Modifies Foreign Body Reaction and Prevents Fibrosis

Local Delivery of Pirfenidone by PLA Implants Modifies Foreign Body Reaction and Prevents Fibrosis

Platelet–Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma

Platelet-Tumor Cell Hybrid Membrane-Camouflaged Nanoparticles for Enhancing Therapy Efficacy in Glioma

Contact Info

Product

Resources

About